## Drugs in pipeline for 2019-nCoV

The table below shows the identified drugs in no particular order. Only ones with preclinical and clinical records for 2019-nCoV were collected from different sources. Those suggested by expert systems or predictive models and traditional Chinese herbs were excluded. 

| Drug Name          | Structure                                                    | MoA                                         | Indication                                                   | DrugBank URL                                     | Anti-2019nCoV Evidence          | Reference                                                    |
| ------------------ | ------------------------------------------------------------ | ------------------------------------------- | ------------------------------------------------------------ | ------------------------------------------------ | ------------------------------- | ------------------------------------------------------------ |
| Lopinavir          | ![img1](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_lopinavir.png) | Protease inhibitor                          | Anti-HIV approved                                            | [DB01601](https://www.drugbank.ca/drugs/DB01601) | Clinical trial                  | [1](http://www.chictr.org.cn/showprojen.aspx?proj=48684); [2](http://www.chictr.org.cn/showprojen.aspx?proj=48919); [3](http://www.chictr.org.cn/showprojen.aspx?proj=48809); [4](http://www.chictr.org.cn/showprojen.aspx?proj=48991); [5](http://www.chictr.org.cn/showprojen.aspx?proj=48782); [6](http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml) |
| Ritonavir          | ![img2](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_ritonavir.png) | Protease inhibitor                          | Anti-HIV approved                                            | [DB00503](https://www.drugbank.ca/drugs/DB00503) | Clinical trial                  | [1](http://www.chictr.org.cn/showprojen.aspx?proj=48684); [2](http://www.chictr.org.cn/showprojen.aspx?proj=48919); [3](http://www.chictr.org.cn/showprojen.aspx?proj=48809); [4](http://www.chictr.org.cn/showprojen.aspx?proj=48991); [5](http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml); [6](http://www.chictr.org.cn/showprojen.aspx?proj=48782) |
| Emtricitabine      | ![img13](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_emtricitabine.png) | nucleoside reverse  transcriptase inhibitor | Anti-HIV  approved, anti-HBV                                 | [DB00879](https://www.drugbank.ca/drugs/DB00879) | Clinical trial                  | [2](http://www.chictr.org.cn/showprojen.aspx?proj=48919)     |
| Tenofovir          | ![img14](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_tenofovir.png) | nucleoside reverse  transcriptase inhibitor | Anti-HIV Phase III, anti-HBV                                 | [DB14126](https://www.drugbank.ca/drugs/DB14126) | Clinical trial                  | [2](http://www.chictr.org.cn/showprojen.aspx?proj=48919)     |
| Ribavirin          | ![img12](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_ribavirin.png) | viral mRNA and  protein synthesis inhibitor | Anti-HCV,  Anti-HBV, Anti-SARS, Anti-influenza, etc          | [DB00811](https://www.drugbank.ca/drugs/DB00811) | Clinical trial                  | [5](http://www.chictr.org.cn/showprojen.aspx?proj=48782)     |
| Umifenovir         | ![img5](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_arbidol.png) |                                             | Influenza approved, nCoV Phase 4                             | [DB13609](https://www.drugbank.ca/drugs/DB13609) | Clinical trial                  | [9](https://clinicaltrials.gov/ct2/show/NCT04246242)         |
| Favipiravir        | ![img6](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_favipiravir.png) | RNA polymerase inhibitor                    | Anti-influenza approved, anti-Ebola Phase II                 | [DB12466](https://www.drugbank.ca/drugs/DB12466) | Clinical trial                  | [10](http://www.xinhuanet.com/english/2020-02/01/c_138747115.htm) |
| Darunavir          | ![img10](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_darunavir.png) | Protease inhibitor                          | Anti-HIV approved                                            | [DB01264](https://www.drugbank.ca/drugs/DB01264) | Clinical trial                  | [11](http://www.chictr.org.cn/showprojen.aspx?proj=48992)    |
| Cobicistat         | ![img11](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_cobicistat.png) |                                             | Anti-HIV approved                                            | [DB09065](https://www.drugbank.ca/drugs/DB09065) | Clinical trial                  | [11](http://www.chictr.org.cn/showprojen.aspx?proj=48992)    |
| Methylprednisolone | ![img9](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_methylprednisolone.png) | Corticosteroid                              | nCoV Phase II, allergic asthma and rheumatic disorders approved | [DB00959](https://www.drugbank.ca/drugs/DB00959) | Clinical trial                  | [12](http://www.chictr.org.cn/showprojen.aspx?proj=48777); [13](https://clinicaltrials.gov/ct2/show/NCT04244591) |
| IFN alpha-1b       |                                                              | Immunomodulation                            | Interferon                                                   |                                                  | Clinical trial                  | [5](http://www.chictr.org.cn/showproj.aspx?proj=48782); [6](http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml) |
| Remdesivir         | ![img3](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_remdesivir.png) | RNA  polymerase inhibitor                   | Anti-Ebola passed Phase III                                  | [DB14761](https://www.drugbank.ca/drugs/DB14761) | In Vitro Assay, Clinical report | [7](http://www.xinhuanet.com/english/2020-01/30/c_138742163.htm); [8](https://www.nejm.org/doi/10.1056/NEJMoa2001191) |
| Chloroquine        | ![img4](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/structure_chloroquine.png) |                                             | Antimalarial approved, anti-HIV phase III, anti-HCV          | [DB14761](https://www.drugbank.ca/drugs/DB14761) | In Vitro Assay                  | [7](http://www.xinhuanet.com/english/2020-01/30/c_138742163.htm) |

[Download (including SMILES structures)](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_clinicalncov.csv)


## Clinical Trials registration list

A list of registered clinical trials related to 2019-nCoV is collected in the table below. This data was initially collected from [Biocentury](https://www.biocentury.com/article/304368) and sorted based on registration date.

| Registration number                                          | Intervention                                                 | Type                      | Registration date |
| ------------------------------------------------------------ | ------------------------------------------------------------ | ------------------------- | ----------------- |
| [ChiCTR2000029308](http://www.chictr.org.cn/showprojen.aspx?proj=48684) | Lopinavir/ritonavir; interferon α 2b                         | Antiviral                 | 2020/1/23         |
| [ChiCTR2000029386](http://www.chictr.org.cn/showprojen.aspx?proj=http://www.chictr.org.cn/showprojen.aspx?proj=48777) | Lopinavir/ritonavir; methylprednisolone; interferon α        | Antiviral; Corticosteroid | 2020/1/28         |
| [ChiCTR2000029387](http://www.chictr.org.cn/showprojen.aspx?proj=48782) | Lopinavir/ritonavir; ribavirin; interferon α-1b              | Antiviral                 | 2020/1/28         |
| [NCT04244591](https://clinicaltrials.gov/ct2/show/NCT04244591) | Methylprednisolone                                           | Corticosteroid            | 2020/1/28         |
| [NCT04246242](https://clinicaltrials.gov/ct2/show/NCT04246242) | Arbidol umifenovir                                           | Antiviral                 | 2020/1/29         |
| [ChiCTR2000029468](http://www.chictr.org.cn/showprojen.aspx?proj=48919) | Lopinavir/ritonavir; emtricitabine/tenofovir alafenamide fumarate | Antiviral                 | 2020/2/2          |
| [ChiCTR2000029496](http://www.chictr.org.cn/showprojen.aspx?proj=48809) | Lopinavir/ritonavir; Novaferon                               | Antiviral                 | 2020/2/3          |
| [ChiCTR2000029539](http://www.chictr.org.cn/showprojen.aspx?proj=48991) | Lopinavir/ritonavir                                          | Antiviral                 | 2020/2/3          |
| [ChiCTR2000029541](http://www.chictr.org.cn/showprojen.aspx?proj=48992) | Darunavir/cobicistat; Lopinavir/ritonavir; thymosin          | Antiviral                 | 2020/2/3          |


## Potential drug candidates by drug repuposing

High-quality drug datasets were collected then curated based on anti-coronavirus indicators. These drugs could be used for drug repuposing.

 * Datasets: 
   * [Drugs in pipeline for SARS](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_clinicaldrug_sars.csv)
   * [Drugs in pipeline for MERS](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_clinicaldrug_mers.csv)
   * [Drugs in pipeline for Coronavirus](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_clinicaldrug_cov.csv)

 * Dataset: [FDA approved set from Drugbank (Downloaded on 07.2018)](http://ghddiai.oss-cn-zhangjiakou.aliyuncs.com/file/file_druglist_drugbank201807.csv)
   * Please visit [Drugbank](https://www.drugbank.ca/) to download the most recent data



## References

[1] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48684); 

[2] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48919); 

[3] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48809); 

[4] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48991); 

[5] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48782)

[6] [National Health Commission of the PRC](http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml)

[7] [Xinhua News](http://www.xinhuanet.com/english/2020-01/30/c_138742163.htm)

[8] [New England Journal of Medicine](https://www.nejm.org/doi/10.1056/NEJMoa2001191)

[9] [NIH ClinicalTrials.gov](https://clinicaltrials.gov/ct2/show/NCT04246242)

[10] [Xinhua News](http://www.xinhuanet.com/english/2020-02/01/c_138747115.htm)

[11] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48992)

[12] [ChiCTR](http://www.chictr.org.cn/showprojen.aspx?proj=48777) 

[13] [NIH ClinicalTrials.gov](https://clinicaltrials.gov/ct2/show/NCT04244591)

